Jordanian drug manufacturers have applied for approvals by the Jordan Food and Drug Administration to produce biological medicines, Jordan Times has reported. All drugs currently manufactured in the kingdom are chemical-based pharmaceuticals, the JFDA said. Pending the administration's review, two manufacturers could start producing biological drugs in the next two-to-three months, JFDA director general Mohammad Rawashdeh said.
Subscribe to MEED to receive your choice of premium newsletters
 |
 |
 |
 |
Identify and track projects across the Middle East and North Africa through MEED Projects. Subscribers can track projects, conduct trend analysis, forecast, produce strategic reports and ultimately win new business.
Middle East data, research and analysis - from broad macroeconomic statistics to specific sector data, MEED Insight can help you accurately and cost effectively forecast market growth and trends.
MEED Events provide high profile speakers, relevant and critical business content and the latest news from across the GCC. With a portfolio that includes large-scale summits, two-day industry specific conferences and unique networking opportunities.
Site powered by Webvision
Share
